Home » Authors » Don Long

Don Long

Articles

ARTICLES

Cure, Not Just Therapy, Target For Cardio Drugs And Devices

Feb. 22, 2002

Cure, Not Just Therapy, Target For Cardio Drugs And Devices

Feb. 22, 2002

Heart disease No. 1 ranking still drives device, drug sectors

Feb. 1, 2002

Abiomed reports it's 'more confident than ever' about AbioCor

Feb. 1, 2002

Alphatec and Luna Innovations file for initial public offerings

Oct. 1, 2000

Pursuing Holy Grail, technology produces spin-off support for heart

Aug. 1, 2000

DeBakey VAD latest in pioneering efforts

July 1, 2000

HIMA grapples with medical technology's new global dilemma: Benefits vs. costs

May 1, 2000

Emphasizing 'the story behind the products'

May 1, 2000

View All Articles by Don Long

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.